Last reviewed · How we verify
NCT07173660: DBS_Consensus
Consensus Statements on Deep Brain Stimulation in Patients With Parkinson's Disease
trial testing Delphi study in Deep Brain Stimulation in 30 participants. Not yet recruiting.
15 November 2025
Quick facts
| Lead sponsor | University Magna Graecia |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 15 September 2025 |
| Primary completion | 15 November 2025 |
| Estimated completion | 1 April 2026 |
Drugs / interventions tested
- Delphi study
Conditions studied
- Deep Brain Stimulation — all drugs for Deep Brain Stimulation →
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
University Magna Graecia
Who can join
18 and older, any sex, with Deep Brain Stimulation or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Deep brain stimulation (DBS) has become a cornerstone therapy for advanced Parkinson's disease (PD), showing superior outcomes over best medical treatment in randomized clinical trials. By delivering adjustable electrical stimulation to key basal ganglia targets, DBS improves tremor, rigidity, bradykinesia, and motor fluctuations, while also reducing dopaminergic medication requirements. Its success, however, depends not only on precise surgical targeting but also on careful patient selection, multidisciplinary planning, and structured long-term follow-up. In Italy, PD affects nearly 176,000 individuals, of whom an estimated 2-4.5% are potential candidates for DBS. A national survey conducted by the Italian Neurosurgery Society (SINch) revealed marked heterogeneity in surgical approaches, target selection, and team composition across DBS centers-reflecting similar international variability. Yet, clear national indications and guidelines have not been established. To address this gap, we conducted an expert consensus using the Delphi methodology.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07173660
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Delphi study
Trials testing the same drug.
- NCT06916598 — Consensus Statements on Definition, Components and Grading of Postoperative Pulmonary Complications · enrolling by invitation
- NCT05422872 — Delphi Study on Psychological Safety Competencies in Healthcare Training Curricula · completed
- NCT03427294 — Delphi Study on Rehabilitation Following Lumbar Arthrodesis · completed
Other recruiting trials for Deep Brain Stimulation
Currently open trials in the same condition.
- NCT07376278 — Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's Disease · recruiting
- NCT06909045 — Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease · NA · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07176494 — Revision of Deep Brain Stimulator in Patients With Parkinson's Disease · NA · recruiting
- NCT06960096 — Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study · recruiting
Other University Magna Graecia trials
Trials by the same sponsor.
- NCT06830460 — Measurement of the Optic Nerve Diameter in Different Healthcare Operators · NA · not yet recruiting
- NCT06274931 — Analysis of the Pulmonary Microbiome · unknown
- NCT05398289 — FOUR-SIX TRIAL for the Treatment of Enterococcal Endocarditis · Phase 4 · not yet recruiting
- NCT05681962 — Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy · recruiting
- NCT05693298 — High Flow Nasal Cannula in Patients Undergoing Gastroscopy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07173660 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Magna Graecia
- Last refreshed: 23 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07173660.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing